Related Experiment Video
Updated: Jul 20, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Hemostasis and glycemic control in the cardiac surgical patient
1Department of Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1009, USA. tslaught@wfubmc.edu
Insights
Diabetes mellitus, particularly type 2, is rising due to lifestyle factors. High blood glucose and insulin levels promote blood clot formation, increasing cardiovascular risk, especially during surgery.
Area of Science:
- Endocrinology and Metabolism
- Cardiovascular Medicine
- Hematology
Background:
- Diabetes mellitus affects 6% of the US population, with a significant portion undiagnosed.
- Type 2 diabetes is increasing due to obesity, inactivity, and aging, leading to insulin resistance.
- Diabetes is a major cause of blindness, kidney failure, and amputations, and is linked to atherothrombotic disease.
Purpose of the Study:
- To review the association between diabetes, hyperglycemia, hyperinsulinemia, and prothrombotic states.
- To highlight the role of hemostasis alterations in diabetes-related cardiovascular risk.
- To emphasize the importance of perioperative glucose control.
Main Methods:
- Review of existing literature on diabetes, hemostasis, endothelial function, and cardiovascular risk.
- Analysis of data linking hyperglycemia and hyperinsulinemia to prothrombotic changes.
- Examination of the inflammatory phenotype in diabetic endothelial dysfunction.
Main Results:
- Hyperglycemia and hyperinsulinemia induce prothrombotic conditions: increased PAI-1, reduced fibrinolysis, elevated coagulation factors (fibrinogen, factor VII, factor X), and enhanced platelet activation.
- Even minor elevations in fasting glucose increase cardiovascular risk.
- Endothelial dysfunction with an inflammatory phenotype is common in diabetes.
Conclusions:
- Alterations in hemostasis significantly contribute to the increased cardiovascular risk in diabetes.
- The prothrombotic potential of hyperglycemia necessitates aggressive perioperative glucose management.
- Controlling blood glucose is crucial for mitigating diabetes-related complications and cardiovascular events.
Abstract:
The Centers for Disease Control and Prevention estimate that 6% of the US population meets diagnostic criteria for diabetes mellitus, with at least one third of this group being undiagnosed. A majority of adult blindness, renal insufficiency, and limb amputation may be directly attributed to diabetes. Although the incidence of type 1, autoimmune-mediated diabetes remains relatively stable, increasing age, physical inactivity, and obesity have produced explosive growth in insulin resistance and type 2 diabetes. A direct association between diabetes and atherothrombotic disease remains indisputable. However, recent data further suggest that even minor elevations of fasting plasma glucose, in "nondiabetic" subjects, increase cardiovascular risk. Alterations in hemostasis may play an important contributory role. Both hyperglycemia and hyperinsulinemia induce prothrombotic characteristics, including overexpression of vascular endothelial plasminogen activator inhibitor-1 (PAI-1), down-regulation of fibrinolysis, elevation of plasma coagulation proteins (ie, fibrinogen, factor VII, factor X), and enhanced platelet activation. Furthermore, endothelial dysfunction-characterized by an inflammatory phenotype-commonly accompanies diabetes. Given data supporting prothrombotic potential of both acute and chronic hyperglycemia, aggressive perioperative glucose control appears imperative.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Hypoglycemia and Glucagon
Peripheral Artery Disease V: Postoperative Nursing Management
Cardiac Catheterization IV: Nursing Management
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Cardiac Catheterization I: Pre-Procedure Overview